Contrast Imaging Guidance Outlines Labeling Change Requirements
This article was originally published in The Gray Sheet
Executive Summary
Imaging device makers may be able to expand their labeling to incorporate new contrast agents without having to seek a change in the imaging drug's label, according to new guidance